SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

Dr. Andrés Rodríguez - 21 May, 2026 0

This presentation, delivered during EuroPCR 2026, analyzed the clinical outcomes of clopidogrel monotherapy versus aspirin in patients who remained event-free for 12 months after...

EuroPCR 2026 | Are bioresorbable stents making a comeback? Five-year results of FUTURE-II with Firesorb

Dr. Juan Manuel Pérez - 21 May, 2026 0

The first bioresorbable coronary scaffolds generated great expectations because of their potential to restore vascular physiology after device resorption. However, early studies such as...

EuroPCR 2026 | Coronary bioadaptor: fewer events regardless of IVUS or FFR guidance

Dr. Juan Manuel Pérez - 21 May, 2026 0

Despite the increasing use of intracoronary imaging and physiology, stent-related events continue to occur at an annual rate of approximately 2–3% beyond the first...

Noticias Institucionales

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

solaci - 21 May, 2026 0

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

solaci - 20 May, 2026 0

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

solaci - 19 May, 2026 0

The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: Moderna

Myocarditis and mRNA COVID-19 Vaccines: New Information from the CDC

COVID-19 Risk in Vaccinated Healthcare Workers

Myocarditis and Messenger RNA COVID-19 Vaccine: What Is the Risk?

Efficacy of the Moderna COVID-19 Vaccine